Actinium Pharmaceuticals, Inc.
ATNM- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001388320
No open-market purchases or sales by Actinium Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $5.18M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Actinium Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 37 | 1 | 43 | +7 |
| Shares | 1.73M | 1.50K | 1.93M | +207.4K (+12.0%) |
| Value | $13.7M | $12.0K | $17.1M | +$3.48M (+25.5%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| ACT Capital Management, LLC | 37,500 | $332.0K | 0.17% |
| D. E. Shaw & Co., Inc. | 28,119 | $249.0K | 0.00% |
| Sabby Management, LLC | 26,488 | $235.0K | 0.05% |
| Marshall Wace, LLP | 22,469 | $199.0K | 0.00% |
| ExodusPoint Capital Management, LP | 17,800 | $158.0K | 0.00% |
| Wealthspire Advisors, LLC | 14,348 | $127.0K | 0.00% |
| Dimensional Fund Advisors LP | 11,079 | $98.0K | 0.00% |
| Citadel Advisors LLC | 11,001 | $98.0K | 0.00% |
| Federation des caisses Desjardins du Quebec | 2,100 | $18.6K | 0.00% |
| Total Clarity Wealth Management, Inc. | 500 | $4.00K | 0.00% |
| Banque Cantonale Vaudoise | 309 | $3.00K | 0.00% |
| Glassman Wealth Services | 200 | $2.00K | 0.00% |
Sold out (5)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| First Trust Advisors LP | 51,273 | $406.0K |
| Pinnacle Associates Ltd | 34,333 | $272.0K |
| Susquehanna International Group, LLP | 22,033 | $174.0K |
| Gemmer Asset Management LLC | 400 | $3.00K |
| Trust Co of Vermont | 50 | $0 |
Not filed for Q3 2021 yet (1)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| CWM, LLC | 1,498 | $12.0K |